1. Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study. (September 2020) Authors: Kamiya, Makoto; Sabia, Helene D.; Marella, Julie; Fava, Maurizio; Nemeroff, Charles B.; Umeuchi, Hideo; Iijima, Michihiko; Chaki, Shigeyuki; Nishino, Izumi Journal: Journal of psychiatric research Issue: Volume 128(2020) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prediction of a clinically effective dose of THY1773, a novel V1Breceptor antagonist, based on preclinical data. (3rd April 2021) Authors: Inatani, Shoko; Mizuno‐Yasuhira, Akiko; Kamiya, Makoto; Nishino, Izumi; Sabia, Helene D.; Endo, Hiromi Journal: Biopharmaceutics & drug disposition Issue: Volume 42:Number 5(2021) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗